Sanfilippo syndrome, also referred to as Mucopolysaccharidosis III, is a rare genetic disorder characterized by a deficiency of specific enzymes in the body’s metabolism. This neurodegenerative condition encompasses various subtypes, each with its own distinct set of symptoms. The overall occurrence rate of all subtypes combined is estimated to be approximately one in every 70,000 births.
Disease Process
Understanding the Disease Process of Sanfilippo Syndrome
In the human body, long-chain sugar molecules play a crucial role in several essential functions, such as blood clotting, skin formation, and connective tissue development. These sugars are continuously broken down and replenished by the body. One specific sugar, called heparan sulfate, is involved in these processes.
However, in the case of Sanfilippo syndrome, a rare genetic disorder, a child inherits a mutation that hinders the production of the necessary enzyme responsible for breaking down heparan sulfate. Consequently, without this vital enzyme, heparan sulfate begins to accumulate within the cells, leading to the manifestation of various symptoms associated with the syndrome.
Classification of Sanfilippo Syndrome
Sanfilippo syndrome can be classified into four subtypes based on the specific enzyme affected by the genetic mutation. While all subtypes are considered to be rare, type A is the most prevalent, followed by type B. Type C is less common, and only a few cases of type D have been documented in research studies. Despite the variations in severity, the symptoms of each subtype do overlap to some extent.